Marshall Wace LLP Purchases 37,380 Shares of Enhabit, Inc. (NYSE:EHAB)

Marshall Wace LLP raised its position in Enhabit, Inc. (NYSE:EHAB - Free Report) by 4.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 949,426 shares of the company's stock after purchasing an additional 37,380 shares during the quarter. Marshall Wace LLP owned 1.89% of Enhabit worth $7,415,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in EHAB. FMR LLC raised its holdings in shares of Enhabit by 138.4% in the third quarter. FMR LLC now owns 3,388 shares of the company's stock worth $27,000 after buying an additional 1,967 shares during the period. Quantbot Technologies LP bought a new position in Enhabit in the 4th quarter valued at $45,000. Corient Private Wealth LLC purchased a new stake in Enhabit in the fourth quarter worth $79,000. Stoneridge Investment Partners LLC increased its stake in Enhabit by 22.6% in the fourth quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company's stock worth $98,000 after purchasing an additional 2,308 shares during the period. Finally, Intech Investment Management LLC lifted its position in shares of Enhabit by 27.6% during the fourth quarter. Intech Investment Management LLC now owns 15,481 shares of the company's stock worth $121,000 after purchasing an additional 3,353 shares during the last quarter.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reaffirmed a "buy" rating on shares of Enhabit in a research note on Thursday, March 6th.

Enhabit Trading Up 1.0 %

EHAB opened at $7.30 on Wednesday. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The stock's fifty day moving average is $8.40 and its two-hundred day moving average is $8.00. The company has a market capitalization of $368.25 million, a P/E ratio of -3.14 and a beta of 1.60. Enhabit, Inc. has a 52 week low of $6.85 and a 52 week high of $10.70.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.